Related Experiment Video
Updated: Jun 26, 2025

09:00
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
Published on: April 18, 2025
531
Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis
1Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, Florida, USA.
The Journal of Biological Chemistry
|May 8, 2024
Summary
Extracellular proteases are crucial in cancer progression and metastasis. Understanding their dysregulation offers new therapeutic targets for cancer treatment.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Extracellular proteins and proteases significantly influence cancer development and progression.
- Proteases, including metalloproteases, serine proteases, cysteine proteases, and aspartic proteases, are critical in cancer.
- Dysregulation of protease activity, due to loss of controls and inhibitors, accelerates cancer.
Purpose of the Study:
- To elucidate the role of extracellular proteases in cancer progression and metastasis.
- To highlight the mechanisms by which dysregulated proteases promote tumor growth and spread.
- To emphasize the importance of understanding the extracellular protease network in cancer.
Main Methods:
- Analysis of protease classes and their functions in cancer.
- Investigation of mechanisms driving protease dysregulation in cancer.
- Review of protease substrates, including ECM proteins and cell surface proteins.
Main Results:
- Dysregulated proteases degrade extracellular matrix (ECM), promote tumor growth, and facilitate metastasis.
- Protease activity alters stromal cells and aids tumor immune escape.
- Specific substrates of proteases include ECM proteins, soluble factors, and cell surface proteins.
Conclusions:
- Extracellular proteases are key drivers of cancer progression and metastasis.
- Targeting dysregulated proteases presents a promising avenue for cancer therapy.
- Technological advancements are improving our understanding of extracellular proteolysis in cancer.
Keywords:
aspartic proteasecancer progressioncathepsincysteine proteasedegradomicsextracellular matrixmetalloproteasemetastasisproteaseprotein protease inhibitorproteolysisproteolytic signalingserine proteasetumor microenvironmentzymogenMore Related Videos
Related Concept Videos
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K

